When controlling for cholinesterase inhibitor use, which was less common in MCI‐AD (see Table 1), MCI‐AD was associated with significantly greater total autonomic symptom severity (1.66 times greater than controls [95% CI: 1.10–2.48]). This evidence concerns the gene BCHE and Alzheimer disease.